To obtain credit, study the material and complete the CME Posttest and Evaluation as instructed at the end of each activity.
After completing each of these educational activities, you should be able to achieve the objective given in the activity.
Although not recognized by the DSM-IV, depressive mixed states are common in patients with mood disorders and often present a clinical crisis due to instability (e.g., patients’ rapidly shifting moods, outbursts of anger, and even suicidal impulses). Depressive mixed states are also associated with poorer treatment outcomes, both acute and long-term, compared with pure depressive or manic states. Thus, swift and accurate diagnosis and treatment of depressive mixed states are essential to alleviate symptoms and improve outcomes for patients with bipolar disorders. This activity was designed to meet the needs of participants in CME activities provided by the CME Institute of Physicians Postgraduate Press, Inc., who have requested information on depressive mixed states. There are no prerequisites for participating in this activity.
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The CME Institute of Physicians Postgraduate Press, Inc., designates each of these educational activities for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
In the spirit of full disclosure and in compliance with all ACCME Essential Areas and Policies, the faculty for this CME activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest (i.e., any proprietary entity producing health care goods or services consumed by, or used on, patients) occurring within the 12 months prior to joining this activity. The CME Institute has resolved any conflicts of interest that were identified. The disclosures are as follows:
Dr. Dilsaver has no personal affiliations or financial relationships with any proprietary entity producing health care goods or services consumed by, or used on, patients to disclose relevant to this presentation. [article list]
Dr. Benazzi has received honoraria from and is a member of the speakers bureaus for Wyeth and Eli Lilly and is a stock shareholder of Pfizer. [article list]
In these Brief Reports, investigational information about pharmaceutical agents may be presented that is outside U.S. Food and Drug Administration-approved labeling. This information is intended solely as continuing medical education and is not intended to promote off-label use of any of these medications. Please consult the paragraph titled “Disclosure of Off-Label Usage” at the end of each Brief Report for a complete listing of off-label or investigational uses. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
These activities have undergone a 3-tier review process: (1) the entire faculty of the series discussed the content at a peer-review planning session; (2) the Chair reviewed the activities for accuracy and fair balance; and (3) a member of the External CME Advisory Board reviewed the activities to determine whether the material is evidence-based and objective.
These Brief Reports are developed from the planning series "Mixed Depression: Diagnosis and Treatment Strategies," which was held in July 2007 and was independently developed by the CME Institute of Physicians Postgraduate Press, Inc., pursuant to an educational grant from Eli Lilly and Company. The opinions expressed herein are those of the faculty and do not necessarily reflect the opinions of the CME provider and publisher or the commercial supporter.
 |
|
| Co-Chair Steven C. Dilsaver, MD Co-Chair Franco Benazzi, MD, PhD |
|
| Project Manager | Anna Acerra, BA |
| Electronic Media Manager | F. Grant Whittle, PhD |
| Managing Director | Jane B. Eckstein, MA |
| Associate CME Director | Jennifer G. Alessi, MA |
| Assistant CME Director | Susan K. Beaton, BS |
| CME Editor | Becky Brown Derych, MA |
| CME Coordinator | Diane Brunner |
| External CME Advisory Board | |
Chair Michael H. Ebert, MD Vice Chair Richard C. Shelton, MD |
|
E. Sherwood Brown, PhD, MD Stephanie Cavanaugh, MD Lawrence J. Cohen, PharmD Larry Culpepper, MD, MPH John M. Downs, MD Alan J. Gelenberg, MD |
Paul King, MD Joseph A. Lieberman, III, MD Elizabeth H. B. Lin, MD Frank W. Ling, MD J. Sloan Manning, MD Meir Steiner, MD, PhD |
© 2007 Physicians Postgraduate Press, Inc. |
|
Psychiatrist.com Home
Keyword Search